Cargando…
Label Adherence of Direct Oral Anticoagulants Dosing and Clinical Outcomes in Patients With Atrial Fibrillation
BACKGROUND: Dose adjustment of non‐vitamin K antagonist oral anticoagulants (NOACs) is indicated in some patients with atrial fibrillation (AF), based on selected patient factors or concomitant medications. We assessed the frequency of label adherence of NOAC dosing among AF patients and the associa...
Autores principales: | Yu, Hee Tae, Yang, Pil‐Sung, Jang, Eunsun, Kim, Tae‐Hoon, Uhm, Jae‐Sun, Kim, Jong‐Youn, Pak, Hui‐Nam, Lee, Moon‐Hyoung, Lip, Gregory Y. H., Joung, Boyoung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7429045/ https://www.ncbi.nlm.nih.gov/pubmed/32495677 http://dx.doi.org/10.1161/JAHA.119.014177 |
Ejemplares similares
-
Social Inequalities of Oral Anticoagulation after the Introduction of Non-Vitamin K Antagonists in Patients with Atrial Fibrillation
por: Yu, Hee Tae, et al.
Publicado: (2019) -
The Effect of Integrated Care Management on Dementia in Atrial Fibrillation
por: Yang, Pil-Sung, et al.
Publicado: (2020) -
Early Experience of Novel Oral Anticoagulants in Catheter Ablation for Atrial Fibrillation: Efficacy and Safety Comparison to Warfarin
por: Shin, Dong Geum, et al.
Publicado: (2016) -
Catheter Ablation Improves Mortality and Other Outcomes in Real‐World Patients With Atrial Fibrillation
por: Yang, Pil‐Sung, et al.
Publicado: (2020) -
What Is the Ideal Blood Pressure Threshold for the Prevention of Atrial Fibrillation in Elderly General Population?
por: Park, Yoon Jung, et al.
Publicado: (2020)